Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy P Mendenhall

Showing results (81-90 of 165) with videos related to

Pageof 17
Sort By:
Journal of the American College of Surgeons|May 13, 2008
Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy?Stephen R Grobmyer, Vincent E Mortellaro, Julia Marshall, et al.
International Journal of Particle Therapy|January 31, 2020
Insurance Coverage for Adjuvant Proton Therapy in the Definitive Treatment of Breast CancerWilliam M Mendenhall, Stephanie Smith, Christopher G Morris, et al.
Acta Oncologica (Stockholm, Sweden)|December 30, 2021
Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis M Bryant, R Charles Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2012
Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphomaBradford S Hoppe, Stella Flampouri, Zhong Su, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2007
Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selectionDaniel T Chang, Steven J Feigenberg, Daniel J Indelicato, et al.
American Journal of Clinical Oncology|June 17, 2009
Does surgical closure technique affect early mammographic detection of tumor recurrence after breast-conserving therapy?Heather E Newlin, Daniel J Indelicato, Patricia Abbitt, et al.
Pediatric Blood & Cancer|May 6, 2016
Proton Therapy for Pediatric Hodgkin LymphomaJustin Wray, Stella Flampouri, William Slayton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2022
Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for UniformityAnish A Butala, Christina C Huang, Curtis M Bryant, et al.
American Journal of Clinical Oncology|August 2, 2002
Phase II study of fludarabine combined with interferon-alpha-2a followed by maintenance therapy with interferon-alpha-2a in patients with low-grade non-hodgkin's lymphomaJames W Lynch, David L Hei, Raul C Braylan, et al.
American Journal of Clinical Oncology|August 7, 2009
The management of adult soft tissue sarcomasWilliam M Mendenhall, Daniel J Indelicato, Mark T Scarborough, et al.
Pageof 17

Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
Journal of the American College of Surgeons|May 13, 2008
Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy?Stephen R Grobmyer, Vincent E Mortellaro, Julia Marshall, et al.
International Journal of Particle Therapy|January 31, 2020
Insurance Coverage for Adjuvant Proton Therapy in the Definitive Treatment of Breast CancerWilliam M Mendenhall, Stephanie Smith, Christopher G Morris, et al.
Acta Oncologica (Stockholm, Sweden)|December 30, 2021
Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis M Bryant, R Charles Nichols, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2012
Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphomaBradford S Hoppe, Stella Flampouri, Zhong Su, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2007
Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selectionDaniel T Chang, Steven J Feigenberg, Daniel J Indelicato, et al.
American Journal of Clinical Oncology|June 17, 2009
Does surgical closure technique affect early mammographic detection of tumor recurrence after breast-conserving therapy?Heather E Newlin, Daniel J Indelicato, Patricia Abbitt, et al.
Pediatric Blood & Cancer|May 6, 2016
Proton Therapy for Pediatric Hodgkin LymphomaJustin Wray, Stella Flampouri, William Slayton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2022
Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for UniformityAnish A Butala, Christina C Huang, Curtis M Bryant, et al.
American Journal of Clinical Oncology|August 2, 2002
Phase II study of fludarabine combined with interferon-alpha-2a followed by maintenance therapy with interferon-alpha-2a in patients with low-grade non-hodgkin's lymphomaJames W Lynch, David L Hei, Raul C Braylan, et al.
American Journal of Clinical Oncology|August 7, 2009
The management of adult soft tissue sarcomasWilliam M Mendenhall, Daniel J Indelicato, Mark T Scarborough, et al.
Pageof 17